Drug Trial Radar · NCT02424214
Artificial Oocyte Activation Comparing Tow Different Agents
Last checked: Nov 19, 2026Latest source record: Feb 19, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
450
Actual
Start
Apr 2015
Primary completion
Jan 2016
Study completion Jan 2016
Sponsor
- Lead sponsor
- Ibn Sina HospitalGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- Collaborators
- Al Baraka Fertility Hospital; Banon IVF Center Assiut, Egypt
- First posted
- Apr 22, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Basic science
- Who can join
- Female only, from 18 years, up to 40 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Comparing the efficacy of tow factors for artificial Oocyte Activation for poor quality Oocytes and Teratozoospermia patients.
Conditions
- Oocyte Fertilization
Interventions
Artificial Oocyte activationOther
Ca IonophoreDrug
Strontium ChlorideDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pregnancy rate ( % )Time frame: 9 months
Locations
3 sites in 2 countries. Site status is shown where the registry gives one.
Al Barka fertility center
Manama, Bahrain
Banon Fertility Center
Asyut, Egypt
Ibnsina IVF center
Sohag, Egypt
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.